These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3876402)

  • 21. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a cDNA for a human high-molecular-weight B-cell growth factor.
    Ambrus JL; Pippin J; Joseph A; Xu C; Blumenthal D; Tamayo A; Claypool K; McCourt D; Srikiatchatochorn A; Ford RJ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6330-4. PubMed ID: 8327514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
    Ennist DL; Elkins KL; Cheng SC; Howard M
    J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal response to a human B cell growth factor in patients with common variable immunodeficiency (CVI).
    Ambrus JL; Haneiwich S; Chesky L; McFarland P; Peters MG; Engler RJ
    J Allergy Clin Immunol; 1991 Jun; 87(6):1138-49. PubMed ID: 1646248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.
    Gordon J; Webb AJ; Walker L; Guy GR; Rowe M
    Eur J Immunol; 1986 Dec; 16(12):1627-30. PubMed ID: 3028819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and partial characterization of human intracellular B cell growth factor.
    Sahasrabuddhe CG; Martin B; Maizel AL
    Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
    J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody NIM-R3 substitutes for B-cell growth factor.
    Greenwood MR; Parkhouse RM
    Immunology; 1986 Sep; 59(1):7-13. PubMed ID: 3489671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
    Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
    J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
    Bowen DL; Ambrus JL; Fauci AS
    J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial purification and characterization of B cell growth factor constitutively secreted by human T-cell hybridoma.
    Pathak SK; Tsang KY; Cathcart MK; Arnaud P; Boutin B; Fudenberg HH
    Immunol Lett; 1985; 10(6):339-46. PubMed ID: 3930398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
    Perri RT
    Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional properties of two human B cell growth factor species separated by lectin affinity column.
    Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
    J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the cell surface receptors for human B cell growth factor of 12,000 molecular weight.
    Mehta SR; Grant SR; Maizel AL
    J Immunol; 1986 Oct; 137(7):2210-4. PubMed ID: 3093567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells.
    Uckun FM; Fauci AS; Heerema NA; Song CW; Mehta SR; Gajl-Peczalska K; Chandan M; Ambrus JL
    Blood; 1987 Oct; 70(4):1020-34. PubMed ID: 3498517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cell lines secreting lymphokines. II. BCGF production by a T hybridoma and B cell lines.
    Gozes Y; Epstein N; Halmann M; Bino T; Rosenberg H; Kobiler D
    Dev Biol Stand; 1987; 66():447-55. PubMed ID: 3495463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2).
    Perri RT; Wilson BS; Kay NE
    Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.